RAGE influences the development of aortic valve stenosis in mice on a high fat diet

Experimental Gerontology

Volumn 59, Issue , 2014, Pages 13-20

  Hofmann, Britt ^a   Yakobus, Yuliana ^a   Indrasari, Mailiza ^b   Nass, Norbert ^c   Santos, Alexander Navarrete ^a   Kraus, Frank Bernhard ^a   Silber, Rolf Edgar ^a   Simm, Andreas ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b St Marien Hospital Siegen   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

AGE; Aging; Aortic valve disease; High fat diet; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ANIMAL EXPERIMENT; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; CALCIFICATION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FAT INTAKE; HISTOLOGY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; LIPID DIET; MALE; METABOLIC STRESS; MORPHOMETRICS; MOUSE; NONHUMAN; OBESITY; THICKNESS; WEIGHT GAIN; WILD TYPE; ADVERSE EFFECTS; ANIMAL; AORTIC VALVE STENOSIS; BLOOD; C57BL MOUSE; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; AORTIC VALVE STENOSIS; DIET, HIGH-FAT; LIPIDS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; WEIGHT GAIN;

EID: 84912059645     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.05.001     Document Type: Article

References (31)

1. Aikawa E., Nahrendorf M., Sosnovik D., Lok V.M., Jaffer F.A., Aikawa M., Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
2. Al-Robaiy S., Weber B., Simm A., Diez C., Rolewska P., Silber R.E., Bartling B. The receptor for advanced glycation end-products supports lung tissue biomechanics. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 305:L491-L500.
3. Basta G., Corciu A.I., Vianello A., Del Turco S., Foffa I., Navarra T., Chiappino D., Berti S., Mazzone A. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis 2010, 210:614-618.
4. Brodeur M.R., Bouvet C., Bouchard S., Moreau S., Leblond J., Deblois D., Moreau P. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. PLoS One 2014, 9:e85922.
5. Campbell D.J., Somaratne J.B., Jenkins A.J., Prior D.L., Yii M., Kenny J.F., Newcomb A.E., Schalkwijk C.G., Black M.J., Kelly D.J. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc. Diabetol. 2011, 10:80.
6. Chavakis T., Bierhaus A., Al-Fakhri N., Schneider D., Witte S., Linn T., Nagashima M., Morser J., Arnold B., Preissner K.T., Nawroth P.P. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 2003, 198:1507-1515.
7. Colvee E., Hurle J.M. Maturation of the extracellular material of the semilunar heart values in the mouse. A histochemical analysis of collagen and mucopolysaccharides. Anat. Embryol. (Berl.) 1981, 162:343-352.
8. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
9. Drolet M.C., Roussel E., Deshaies Y., Couet J., Arsenault M. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J. Am. Coll. Cardiol. 2006, 47:850-855.
10. Falcao-Pires I., Hamdani N., Borbely A., Gavina C., Schalkwijk C.G., van der Velden J., van Heerebeek L., Stienen G.J., Niessen H.W., Leite-Moreira A.F., Paulus W.J. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation 2011, 124:1151-1159.
11. Hakuno D., Kimura N., Yoshioka M., Fukuda K. Molecular mechanisms underlying the onset of degenerative aortic valve disease. J. Mol. Med. (Berl.) 2009, 87:17-24.
12. Hartog J.W., Hummel Y.M., Voors A.A., Schalkwijk C.G., Miyata T., Huisman R.M., Smit A.J., Van Veldhuisen D.J. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients. J. Card. Fail. 2008, 14:596-602.
13. Kilhovd B.K., Juutilainen A., Lehto S., Ronnemaa T., Torjesen P.A., Hanssen K.F., Laakso M. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18year follow-up study. Diabetologia 2007, 50:1409-1417.
14. Leuner B., Max M., Thamm K., Kausler C., Yakobus Y., Bierhaus A., Sel S., Hofmann B., Silber R.E., Simm A., Nass N. RAGE influences obesity in mice. Effects of the presence of RAGE on weight gain, AGE accumulation, and insulin levels in mice on a high fat diet. Z. Gerontol. Geriatr. 2012, 45:102-108.
15. Li F., Cai Z., Chen F., Shi X., Zhang Q., Chen S., Shi J., Wang D.W., Dong N. Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products. Basic Res. Cardiol. 2012, 107:306.
16. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., Plachky J., Grone H.J., Kurschus F.C., Schmidt A.M., Yan S.D., Martin E., Schleicher E., Stern D.M., Hammerling G.G., Nawroth P.P., Arnold B. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 2004, 113:1641-1650.
17. Liu Y., Qu Y., Wang R., Ma Y., Xia C., Gao C., Liu J., Lian K., Xu A., Lu X., Sun L., Yang L., Lau W.B., Gao E., Koch W., Wang H., Tao L. The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E841-E852.
18. Matsumoto Y., Adams V., Jacob S., Mangner N., Schuler G., Linke A. Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice. Circulation 2010, 121:759-767.
19. Nass N., Vogel K., Hofmann B., Presek P., Silber R.E., Simm A. Glycation of PDGF results in decreased biological activity. Int. J. Biochem. Cell Biol. 2010, 42:749-754.
20. Nin J.W., Jorsal A., Ferreira I., Schalkwijk C.G., Prins M.H., Parving H.H., Tarnow L., Rossing P., Stehouwer C.D. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011, 34:442-447.
21. Nozynski J., Zakliczynski M., Konecka-Mrowka D., Zakliczynska H., Pijet M., Zembala-Nozynska E., Lange D., Zembala M. Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart. Exp. Gerontol. 2013, 48:223-228.
22. Ott C., Jacobs K., Haucke E., Navarrete Santos A., Grune T., Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014, 2:411-429.
23. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
24. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J., Chow W.S., Stern D., Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 1998, 4:1025-1031.
25. Raposeiras-Roubin S., Rodino-Janeiro B.K., Paradela-Dobarro B., Grigorian-Shamagian L., Garcia-Acuna J.M., Aguiar-Souto P., Jacquet-Hervet M., Reino-Maceiras M.V., Alvarez E., Gonzalez-Juanatey J.R. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report. Cardiovasc. Diabetol. 2012, 11:102.
26. Reddy G.K. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc. Res. 2004, 68:132-142.
27. Simm A. Protein glycation during aging and in cardiovascular disease. J. Proteomics 2013, 92:248-259.
28. Tian Y.Q., Li S.S., Su X.D., Zhang G.Z., Zhao J.J., Li G.W., Wang L. Effects of pioglitazone on high-fat-diet-induced ventricular remodeling and dysfunction in rats. J. Cardiovasc. Pharmacol. Ther. 2012, 17:223-228.
29. Tikellis C., Thomas M.C., Harcourt B.E., Coughlan M.T., Pete J., Bialkowski K., Tan A., Bierhaus A., Cooper M.E., Forbes J.M. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E323-E330.
30. Wei Q., Ren X., Jiang Y., Jin H., Liu N., Li J. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress. BMC Cardiovasc. Disord. 2013, 13:13.
31. Willemsen S., Hartog J.W., Hummel Y.M., van Ruijven M.H., van der Horst I.C., van Veldhuisen D.J., Voors A.A. Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients. Eur. J. Heart Fail. 2011, 13:76-82.